Selective decontamination of the digestive tract (SDD). Twenty-five years of european experience

Intensive and Critical Care Medicine: WFSICCM World Federation of Societies of Intensive and Critical Care Medicine

Volumn , Issue , 2009, Pages 273-283

  Silvestri, Luciano ^a,b   De La Cal, Miguel A ^c   Van Saene, H K F ^d  

^a Presidio Ospedaliero di Gorizia ^*  (Italy)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c HOSPITAL UNIVERSITARIO DE GETAFE   (Spain)

^d UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953611000     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-88-470-1436-7_23     Document Type: Chapter

References (59)

1. Stoutenbeek CP, van Saene HKF, Miranda DR, Zandstra DF (1984) The effect of selective decontamination of the digestive tract on colonisation and infection rate in multiple trauma patients. Intensive Care Med 10:185-192
2. Morar P, Makura Z, Jones A et al (2000) Topical antibiotics on tracheostoma prevent exogenous colonisation and infection of lower airways in children. Chest 117:513-518
3. van Saene HKF, Reilly NJ, de Silvestre A, Nardi G (2005) Antibiotic policies in the intensive care unit. In: van Saene HKF, Silvestri L, de la Cal MA (eds) Infection control in the intensive care unit, 2nd edn. Springer Verlag, Milan, Italy, pp 231-246
4. Vandenbroucke-Grauls CMJ, Vandenbroucke JP (1991) Effect of selective decontamination of the digestive tract on respiratory tract infections and mortality in the intensive care unit. Lancet 338:859-862
5. D?Amico R, Pifferi S, Leonetti C et al (1998) Effectiveness of antibiotic prophylaxis in critically ill adult patients: Systematic review of randomised controlled trials. BMJ 316:1275-1285
6. Liberati A, D?Amico R, Pifferi S et al (2004) Antibiotic prophylaxis to reduce respiratory tract infections and morality in adults receiving intensive care. Cochrane Database Systems 1: CD 000022
7. Safdar N, Said A, Lucey MR (2004) The role of selective digestive decontamination for reducing infection in patients undergoing liver transplantation: a systematic review and metaanalysis. Liver Transpl 10:817-827
8. Silvestri L, van Saene HKF, Milanese M et al (2005) Impact of selective decontamination of the digestive tract on fungal carriage and infection: Systematic review of randomised controlled trials. Intensive Care Med 31:898-910
9. Silvestri L, van Saene HKF, Milanese M et al (2007) Selective decontamination of the digestive tract reduces bacterial bloodstream infections and mortality in critically ill patients. Systematic review of randomised, controlled trials. J Hosp Infect 15:187-203
10. Silvestri L, van Saene HKF, Casarin A et al (2008) Impact of selective decontamination of the digestive tract on carriage and infection due to Gram-negative and Gram-positive bacteria. A systematic review of randomised controlled trials. Anaesth Intensive Care 36:324-338
11. Silvestri L, van Saene HKF, Weir I, Gullo A (2009) Survival benefit of the full selective digestive decontamination regimen. J Crit Care doi:10.1016/j.jcrc.2008.11.005, Epub ahead of print
12. Silvestri L, van Saene HKF (2006) Selective decontamination of the digestive tract does not increase resistance in critically ill patients: evidence from randomised controlled trials. Crit Care Med 34:2027-2030
13. Rocha LA, Martin MJ, Pita S et al (1992) Prevention of nosocomial infection in critically ill patients by selective decontamination of the digestive tract. Intensive Care Med 18:398-404
14. Verwaest C, Verhaegen J, Ferdinande P et al (1997) Randomised controlled trial of selective digestive decontamination in 600 mechanically ventilated patients in a multi-disciplinary intensive care unit. Crit Care Med 25:63-71
15. Brun-Buisson C, Legrand P, Rauss AA et al (1989) Intestinal decontamination for control of nosocomial multi-resistant Gram-negative bacilli. Ann Intern Med 110:873-881
16. de Jonge E, Schultz M, Spanjaard L et al (2003) Effects of selective decontamination of the digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 363:1011-1016
17. de Smet AMGA, Kluytmans JAJW, Cooper BS et al (2009) Decontamination of the digestive tract and oropharynx in ICU-patients. N Engl J Med 360:20-31
18. Stoutenbeek CP, van Saene HKF, Zandstra DF (1987) The effect of oral non-absorbable antibiotics on the emergence of resistant bacteria in patients on an intensive care unit. J Antimicrob Chemother 19:513-520
19. Leone M, Albanese J, Antonini F et al (2003) Long-term (6 year) effect of selective digestive decontamination on antimicrobial resistance in intensive care, multiple-trauma patients. Crit Care Med 31:2090-2095
20. Sarginson RE, Taylor N, Reilly N et al (2004) Infection in prolonged pediatric critical illness: a prospective four year study based on knowledge of the carrier state. Crit Care Med 32:839-847
21. Heininger A, Meyer E, Schwab F et al (2006) Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Intensive Care Med 32:569-676
22. van Saene HKF, Taylor N, Damjanovic V, Sarginson RE (2008) Microbial gut overgrowth guarantees increased spontaneous mutation leading to polyclonality and antibiotic resistance in the critically ill. Curr Drug Targ 9:419-421
23. Arnow PM, Carandang GC, Zabner R et al (1996) Randomised controlled trial of selective bowel decontamination for prevention of infections following liver transplantation. Clin Infect Dis 22:997-1003
24. Hellinger WC, Yao JD, Alvarez S et al (2002) A randomised, prospective, double-blind evaluation of selective bowel decontamination in liver transplantation. Transplantation 73:1904-1909
25. Gastinne H, Wolff M, de la Tour F et al (1992) A controlled trial in intensive care units of selective decontamination of the digestive tract with non-absorbable antibiotics. N Engl J Med 326:594-599
26. Hammond JMJ, Potgieter PD, Saunders GL et al (1992) Double-blind study of selective decontamination of the digestive tract in intensive care. Lancet 340:5-9
27. Ferrer M, Torres A, Gonzalez J et al (1994) Utility of selective decontamination in mechanically ventilated patients. Ann Intern Med 120:389-395
28. Wiener J, Itokazu G, Nathan C et al (1995) A randomised, double-blind, placebo-controlled trial of selective digestive decontamination in a medical-surgical intensive care unit. Clin Infect Dis 20:861-867
29. Lingnau W, Berger J, Javorsky F et al (1997) Selective intestinal decontamination in multiple trauma patients: Prospective, controlled trial. J Trauma 42:687-694
30. de la Cal MA, Cerda E, Garcia-Hierro P et al (2005) Survival benefit in critically ill burned patients receiving selective decontamination of the digestive tract. Ann Surg 241:424-430
31. Silvestri L, Milanese M, Oblach L et al (2002) Enteral vancomycin to control methicillin-resistant Staphylococcus aureus outbreak in mechanically ventilated patients. Am J Infect Control 30:391-399
32. Gaussorgues Ph, Salord F, Sirodot M et al (1991) Nosocomial bacteria in patients under mechanical ventilation and receiving beta-inotropic drugs: efficacy of digestive decontamination. Rean Soins Intens Med Urg 7:169-174
33. Pugin J, Auckenthaler R, Lew DP, Suter PM (1991) Oropharyngeal decontamination decreases incidence of ventilator-associated pneumonia. JAMA 266:2704-2710
34. Korinek AM, Laisne MJ, Nicolas MH et al (1993) Selective decontamination of the digestive tract in neurosurgical intensive care unit patients: a double-blind, randomized, placebo-controlled study. Crit Care Med 21:1468-1473
35. Schardey HM, Joosten U, Finke U et al (1997) The prevention of anastomotic leakage after total gastrectomy with local decontamination. A prospective, randomised, double-blind, placebo- controlled, multicentre trial. Ann Surg 225:172-180
36. Bergmans DCJJ, Bonten MJM, Gaillard CA et al (2001) Prevention of ventilator-associated pneumonia by oral decontamination. A prospective, randomised, double-blind, placebo-controlled study. Am J Respir Crit Care Med 164:382-388
37. Krueger WA, Lenhart FP, Neeser G et al (2002) Influence of combined intravenous and topical antibiotic prophylaxis on the incidence of infections, organ dysfunctions, and mortality in critically ill surgical patients. A prospective, stratified, randomized, double-blind, placebocontrolled clinical trial. Am J Respir Crit Care Med 166:1029-1037
38. de la Cal MA, Cerda E, van Saene HKF et al (2004) Effectiveness and safety of enteral vancomycin to control endemicity of methicillin-resistant Staphylococcus aureus in a medical/surgical intensive care unit. J Hosp Infect 56:175-183
39. Cerda E, Abella A, de la Cal MA et al (2007) Enteral vancomycin controls methicillin-resistant Staphylococcus aureus endemicity in an intensive care burn unit. A 9-year prospective study. Ann Surg 245:397-407
40. Viviani M, van Saene HKF, Dezzoni R et al (2005) Control of imported and acquired methicillin- resistant Staphylococcus aureus (MRSA) in mechanically ventilated patients: a dose- response study of enteral vancomycin to reduce absolute carriage and infection. Anaesth Intensive Care 33:361-372
41. Guerin F, Buu-Hoi A, Mainard JL et al (2000) Outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a Parisian hospital. J Clin Microbiol 38:2985-2988
42. Currie BP, Lemos-Filho L (2004) Evidence for biliary excretion of vancomycin into stool during intravenous therapy: potential implications for rectal colonization with vancomycin-resistant enterococci. Antimicrob Agents Chemother 48:4427-4429
43. Verma N, Clarke RW, Bolton-Maggs PHB et al (2007) Gut overgrowth of vancomycin-resistant enterococci (VRE) results in lineozlid-resistant mutation in a child with severe congenital neutropenia. J Pediatr Hematol Oncol 29:557-560
44. Stiefel U, Paterson DL, Pultz NJ et al (2004) Effect of the increasing use of piperacillin/tazobactam on the incidence of vancomycin-resistant enterococci in four academic medical centres. Infect Control Hosp Epidemiol 25:380-383
45. Salgado CD, Giannetta ET, Farr BM (2004) Failure to develop vancomycin-resistant Enterococcus with oral vancomycin treatment of Clostridium difficile. Infect Control Hosp Epidemiol 25:413-417
46. Quinio B, Albanese J, Bues-Charbit M et al (1996) Selective decontamination of the digestive tract in multiple trauma patients. Chest 169:765-772
47. Collard HR, Saint S (2001) Preventative practices for ventilator-associated pneumonia. Agency for Healthcare Research and Quality Publication 01-E058, Rockville
48. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301-1308
49. Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:799-809
50. Van den Berge G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367
51. Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fluorocortisone on mortality in patients with septic shock. JAMA 288:862-871
52. Grades of Recommendation, Assessment, Development and Evaluation (GRADE) Working Group (2004) Grading quality of evidence and strength of recommendations. BMJ 328:1490-1494
53. Dellinger RPh, Levy MM, Carlet JM et al (2008) Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2008. Crit Care Med 36:296-327
54. van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449-461
55. Devos P, Preiser JC, Melot C (2007) Impact of tight glucose control by intensive insulin therapy on ICU mortality and the role of hypoglycemia: Final results of Glucontrol study. Intensive Care Med 33(Suppl 2):S189
56. Brunkhorst FM, Engel C, Bloos F et al (2008) Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139
57. The NICE-SUGAR study investigators (2009) Intensive vs. conventional glucose control in critically ill patients. N Engl J Med 360:1283-1297
58. Soylemez-Wiener R, Wiener DC, Larson RJ (2008) Benefits and risks of tight glucose control in critically ill adults. JAMA 300:933-944
59. van Saene HKF, Petros AJ, Ramsay G, Baxby D (2003) All great truths are iconoclastic: Selective decontamination of the digestive tract moves from heresy to level 1 truth. Intensive Care Med 29:677-690